Long-term heart function after adjuvant epirubicin chemotherapy for breast cancer

Jon M Appel, Bo Zerahn, Susanne Møller, Heidi M Christensen, Peter Søgaard, Bent Ejlertsen, Niels Fogh-Andersen, Benny V Jensen, Dorte L Nielsen

12 Citationer (Scopus)

Abstract

Newer studies raise concern that adjuvant anthracycline treatment for breast cancer (BC) causes long-term heart damage. We aimed to examine whether heart failure or impairment could be demonstrated several years after low-dose epirubicin-based adjuvant treatment.
OriginalsprogEngelsk
TidsskriftActa Oncologica
Vol/bind51
Udgave nummer8
Sider (fra-til)1054-61
Antal sider8
ISSN0284-186X
DOI
StatusUdgivet - 2012

Fingeraftryk

Dyk ned i forskningsemnerne om 'Long-term heart function after adjuvant epirubicin chemotherapy for breast cancer'. Sammen danner de et unikt fingeraftryk.

Citationsformater